-
青霉素
NMR and HPLC COA下載 MSDS下載 - Names:
Benzylpenicillin
- CAS號(hào):
61-33-6
MDL Number: MFCD00069665 - MF(分子式): C16H18N2O4S MW(分子量): 334.39
- EINECS:200-506-3 Reaxys Number:
- Pubchem ID:5904 Brand:BIOFOUNT
| 貨品編碼 | 規(guī)格 | 純度 | 價(jià)格 (¥) | 現(xiàn)價(jià)(¥) | 特價(jià)(¥) | 庫(kù)存描述 | 數(shù)量 | 總計(jì) (¥) |
|---|---|---|---|---|---|---|---|---|
| DBK500847-500mg | 500mg | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 | |||
| DBK500847-100mg | 100mg | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 |
- 大包裝詢價(jià) 提供各種包裝,敬請(qǐng)垂詢
- 收藏商品 商品點(diǎn)評(píng) 加入購(gòu)物車 立即購(gòu)買
| 中文別名 | 青霉素(CAS:61-33-6),芐青霉素鉀鹽,盤尼西林,青霉素,青霉素 G |
| 英文別名 | Benzylpenicillin(CAS:61-33-6),penicillin g, Benzylpenicillin, Benzylpenicillinic acid, Free penicillin II, Pencillin G, Benzylpenicillin G, Benzyl penicillin, Free penicillin G |
| CAS號(hào) | 61-33-6 |
| Inchi | InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1 |
| InchiKey | JGSARLDLIJGVTE-MBNYWOFBSA-N |
| 分子式 Formula | C16H18N2O4S |
| 分子量 Molecular Weight | 334.39 |
| 溶解度Solubility | 0.285 mg/mL |
| 性狀 | Solid |
| 儲(chǔ)藏條件 Storage conditions | 2-8°C |
| 動(dòng)物 | 測(cè)試類型 | 途徑 | 實(shí)驗(yàn)攝入量 (標(biāo)準(zhǔn)攝入量) | 影響 | 文獻(xiàn)來源 |
| child | TDLo | parenteral | 15000 units/kg (15000 mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGES IN COCHLEAR STRUCTURE OR FUNCTION: EAR; BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD; LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Lancet., 1(394), 1986 [PMID:2868336] |
| rat | LD50 | oral | 8 gm/kg (8000 mg/kg) | Antibiotics and Chemotherapy, 12(249), 1962 | |
| rat | LD50 | unreported | 9 gm/kg (9000 mg/kg) | Antibiotiki., 23(317), 1978 [PMID:646331] | |
| mouse | LD50 | oral | >5 gm/kg (5000 mg/kg) | Antimicrobial Agents and Chemotherapy, -(619), 1967 | |
| mouse | LD50 | intraperitoneal | 3500 mg/kg (3500 mg/kg) | Antimicrobial Agents and Chemotherapy, -(619), 1967 | |
| mouse | LD50 | intravenous | 329 mg/kg (329 mg/kg) | Biochemical Pharmacology., 16(1365), 1967 [PMID:6053601] | |
| mouse | LD50 | intracrebral | 5700 ug/kg (5.7 mg/kg) | BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES | Journal of Laboratory and Clinical Medicine., 34(126), 1949 |
| mouse | LD50 | unreported | 7800 mg/kg (7800 mg/kg) | Antibiotiki., 23(317), 1978 [PMID:646331] | |
| dog | LD50 | intracrebral | 1118 ug/kg (1.1180000000000001 mg/kg) | BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES | Journal of Laboratory and Clinical Medicine., 34(126), 1949 |
| dog | LD50 | unreported | 4940 ug/kg (4.9400000000000004 mg/kg) | BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES | Journal of Laboratory and Clinical Medicine., 34(126), 1949 |
| rabbit | LD50 | intracrebral | 653 ug/kg (0.65300000000000002 mg/kg) | BRAIN AND COVERINGS: OTHER DEGENERATIVE CHANGES | Journal of Laboratory and Clinical Medicine., 34(126), 1949 |
| guinea pig | LD50 | unreported | 38 mg/kg (38 mg/kg) | Gigiena i Sanitariya. For English translation, see HYSAAV., 42(9)(10), 1977 | |
| hamster | LD50 | oral | 24 mg/kg (24 mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY); BEHAVIORAL: FOOD INTAKE (ANIMAL); GASTROINTESTINAL: HYPERMOTILITY, DIARRHEA | Toxicology and Applied Pharmacology., 14(510), 1969 [PMID:5787519] |
| hamster | LD50 | subcutaneous | 96 mg/kg (96 mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY); BEHAVIORAL: FOOD INTAKE (ANIMAL); GASTROINTESTINAL: HYPERMOTILITY, DIARRHEA | Toxicology and Applied Pharmacology., 14(510), 1969 [PMID:5787519] |
青霉素(Benzylpenicillin,61-33-6)使用注意事項(xiàng):
1.實(shí)驗(yàn)前需戴好防護(hù)眼鏡,穿戴防護(hù)服和口罩,佩戴手套,避免與皮膚接觸。
2.實(shí)驗(yàn)過程中如遇到有毒或者刺激性物質(zhì)及有害物質(zhì)產(chǎn)生,必要時(shí)實(shí)驗(yàn)操作需要手套箱內(nèi)完成以免對(duì)實(shí)驗(yàn)人員造成傷害。
3.取樣品的移液槍頭需及時(shí)更換,必要時(shí)為避免交叉污染盡可能選擇濾芯吸頭。
4.稱量藥品時(shí)選用稱量紙,并無風(fēng)處取藥和稱量以免揚(yáng)撒,試劑的容器使用前務(wù)必確保干凈,并消毒。
5.取藥品時(shí)盡量采用多個(gè)藥勺分別使用,使用后清洗干凈。
6.實(shí)驗(yàn)后產(chǎn)生的廢棄物需分類存儲(chǔ),并交于專業(yè)生物廢氣物處理公司處理,以免造成環(huán)境污染。
大規(guī)格定制:定制產(chǎn)品請(qǐng)將信息發(fā)送至sales@bio-fount.com。
Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
Tag:青霉素蒸汽壓,青霉素合成,青霉素標(biāo)準(zhǔn),青霉素應(yīng)用,青霉素合成,青霉素沸點(diǎn),青霉素閃點(diǎn),青霉素用途,青霉素溶解度,青霉素價(jià)格,青霉素作用,青霉素結(jié)構(gòu)式,青霉素用處,青霉素毒理性質(zhì),青霉素MSDS
| 產(chǎn)品說明 | 青霉素(61-33-6)是一種廣譜,β-內(nèi)酰胺的天然青霉素抗生素,青霉素具有抗菌活性.青霉素溶解度,青霉素msds,青霉素結(jié)構(gòu)式詳見主頁(yè). |
| Introduction | Benzylpenicillin (青霉素,61-33-6)is a broad-spectrum, beta-lactam naturally occurring penicillin antibiotic with antibacterial activity. |
| Application1 | By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, penicillin G inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that penicillin G interferes with an autolysin inhibitor.TargetActionsOrganismUPenicillin-binding protein 3inhibitorStaphylococcus aureus (strain USA300)USolute carrier family 22 member 8substrateinhibitorHumansUSolute carrier family 15 member 1substrateinhibitorHumansUSolute carrier family 15 member 2inhibitorHumans |
| Application2 | |
| Application3 |
1.Penicillin G is a broad-spectrum, beta-lactam naturally occurring penicillin antibiotic with antibacterial activity. Penicillin G binds to and inactivates the penicillin binding proteins (PBPs) located inside the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and eventually causing cell lysis.
2.Penicillin G is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms. Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions.
3.Penicillin G and V are first generation penicillins that are used widely to treat infections due to susceptible organisms and have been linked rarely and only weakly with idiosyncratic liver injury.
| 警示圖 | |
| 危險(xiǎn)性 | |
| 危險(xiǎn)性警示 | warning |
| 安全聲明 | |
| 安全防護(hù) | |
| 備注 | 實(shí)驗(yàn)過程中防止吸入、食如,做好安全防護(hù) |
| Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective International orthopaedics 2020-08-01 32445030 |
| A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran The Science of the total environment 2020-07-10 32283308 |
| Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections AIDS reviews 2020-07-08 |
| A man in his nineties with fever and dry cough Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020-04-21 32321232 |
| Effect of penicillin G on the biliary excretion of cholephilic compounds in rats?? ?Journal of Hepato-Biliary-Pancreatic Sciences?? ?2011 |
Abstract:
Aim:Penicillin G is reported to increase bile flow by increasing biliary glutathione excretion, as well as the biliary excretion of penicillin G itself. In order to study the effect of penicillin G on the hepatic excretory pathway, the effect of colchicine and genipin on the increase of biliary glutathione excretion induced by penicillin G was studied in rats. The effect of penicillin G on the biliary excretion of sulfobromophthalein and erythromycin was also studied, together with the effect of penicillin G on cholestasis induced by estradiol‐17β‐glucuronide.
Methods:After bile duct cannulation, penicillin G was administered to rats at the rate of 0.5 μmol/min/100 g. The effect was examined of colchicine pretreatment (0.2 mg/100 g) and genipin administration (0.5 μmol/min/100 g) on biliary glutathione excretion increased by penicillin G infused at the rate of 0.5 μmol/min/100 g. The effect of penicillin G on the biliary excretion of sulfobromophthalein and erythromycin (0.2 and 0.1 μmol/min/100 g for 90 min, respectively) was studied, together with the effect of penicillin G on cholestasis induced by estradiol‐17β‐glucuronide (0.075 μmol/min/100 g for 20 min).
Results:Penicillin G increased bile flow and biliary glutathione excretion, which were not inhibited by colchicine or genipin. Biliary penicillin G excretion was markedly reduced in Eisai hyperbilirubinemic rats (EHBR) and Mrp2‐deficient rats. Biliary sulfobromophthalein and erythromycin excretion was unchanged by penicillin G. Cholestasis induced by estradiol‐17β‐glucuronide was not relieved by penicillin G.
Conclusions:It was shown that colchicine‐sensitive vesicular transport has no role on the penicillin G‐induced insertion of Mrp2 into the canalicular membrane, as has been observed with genipin. Although the choleresis of penicillin G is thought to be due to the increased biliary excretion of glutathione and penicillin G itself by Mrp2, the mechanism of Mrp2 insertion by penicillin G is thought to be partly different from that by genipin.
2.Facilitated Transport of Penicillin G by Bulk Liquid Membrane with TBP as Carrier/Zhongqi Ren, Yuanyuan Lv & Weidong Zhang Applied Biochemistry and Biotechnology volume 152, pages286–294 (2009)
2.Facilitated Transport of Penicillin G by Bulk Liquid Membrane with TBP as Carrier/Zhongqi Ren, Yuanyuan Lv & Weidong Zhang Applied Biochemistry and Biotechnology volume 152, pages286–294 (2009)
Abstract:The facilitated transport of penicillin G from aqueous solutions to the stripping phase through bulk liquid membrane (BLM) containing TBP in 3% iso-octanol and n-butyl acetate was studied. Na2CO3 solution was used as the stripping phase. Experiments were performed as a function of stirring rate, TBP concentration and type of diluent in the liquid membrane phase, pH, and initial penicillin G concentration in the feed phase, Na2CO3 concentration in the stripping phase, etc. The results showed that the BLM process could carry out the simultaneous separation and concentration of penicillin G from dilute aqueous solutions, and arise “up-hill” effect due to the characteristic of non-equilibrium mass transfer. The diffusion of penicillin G complex in the liquid membrane phase played an important role in BLM process. The mass transfer mechanism of BLM for this system was also discussed.
- 相關(guān)產(chǎn)品
-
< >
- 推薦產(chǎn)品
-
< >
- 最新產(chǎn)品
-
< >
新聞
胞爬片免疫組化染色.png)
怎么做細(xì)胞爬片免疫組化染色實(shí)驗(yàn)
細(xì)胞爬片免疫組化染色,是通過細(xì)胞爬片是讓玻片浸在細(xì)胞培養(yǎng)基內(nèi),細(xì)胞在玻片上生長(zhǎng),主要用于組織學(xué),免疫組織化學(xué)...
2020/7/20 22:04:33

提取病毒RNA的實(shí)驗(yàn)方法
提取病毒RNA方法分別有:異硫氰酸胍的提取病毒RNA方法、TRIzol LS提取法、Trizol法提取法等等...
2020/7/22 20:29:26

9月開學(xué)季——助研新學(xué)期 范德送好禮
2025/8/28 15:30:55

Waxfilm 實(shí)驗(yàn)室封口膜:技術(shù)與國(guó)際市場(chǎng)的雙重突破
在實(shí)驗(yàn)室耗材領(lǐng)域,封口膜是保障實(shí)驗(yàn)準(zhǔn)確性與穩(wěn)定性的關(guān)鍵產(chǎn)品之一。近年來,Waxfilm?實(shí)驗(yàn)室封口膜憑借其卓...
2025/5/13 13:03:40

Waxfilm實(shí)驗(yàn)室封口膜的5大突破
Waxfilm實(shí)驗(yàn)室封口膜作為生物功能膜領(lǐng)域的國(guó)產(chǎn)技術(shù)突破和品牌突破,是生物領(lǐng)域中國(guó)技術(shù)發(fā)展的縮影。
2025/5/6 17:02:07

各種微流控芯片鍵合方法的優(yōu)缺點(diǎn)
微流控芯片鍵合:目前主要有激光焊接、熱壓鍵合、膠鍵合、超音波焊接,每種方法都有各自的優(yōu)缺點(diǎn)。本文主要介紹聚酯...
2023/7/28 10:43:09

新一代微流控鍵合解決方案
微流控鍵合解決方案:微流控芯片制造的一個(gè)重要環(huán)節(jié),也是最容易被忽視的--芯片鍵合。其中一個(gè)重要因素是:微流控...
2023/7/27 12:44:28
驗(yàn)動(dòng)物圖.png)
熒光素鉀鹽使用說明
D-熒光素鉀鹽(K+)設(shè)計(jì)用于體外和體內(nèi)生物發(fā)光測(cè)定。D-熒光素的質(zhì)量和純度對(duì)于獲得良好和可重復(fù)的結(jié)果至關(guān)重...
2023/7/20 11:05:11

如何選BSA(牛血清白蛋白)
如何選BSA(牛血清白蛋白):牛血清白蛋白(BSA)有多種形式,如何選擇適合自己的牛血清白蛋白(BSA)是一...
2023/2/14 13:09:18

牛血清白蛋白(BSA)常見問題
牛血清白蛋白(BSA)常見問題:牛血清白蛋白(BSA)在實(shí)驗(yàn)室中是通用的,可用于蛋白質(zhì)印跡、細(xì)胞組織培養(yǎng)、P...
2022/10/19 9:39:51



購(gòu)物車 


